Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure

Niraj Khandelwal, Laura P. James, Corron Sanders, Anne M. Larson, William M. Lee

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Despite extensive investigations, the cause of liver injury in 14% of patients with acute liver failure remains unknown (indeterminate). In a pilot study using a novel assay, highly specific acetaminophen-cysteine adducts were detected in 7 of 36 indeterminate patients (19%). To extend these observations, sera from 110 subjects enrolled in the Acute Liver Failure Study Group registry with indeterminate acute liver failure were analyzed with a similar but more efficient and sensitive adduct assay. As positive controls, another 199 patients with known or presumed acetaminophen-induced liver failure were assessed for the presence and quantity of adducts. Clinical, laboratory, and outcome data were compared for the two groups. On the basis of previous data for known therapeutic exposures and acetaminophen overdoses, an adduct concentration ≥1.0 nmol/mL of serum indicated a definite acetaminophen overdose. Among the 110 indeterminate cases, 18% had assay values ≥1.0 with a median level of 9.2 nmol/mL; 94.5% of the positive controls (known acetaminophen cases) had values ≥1.0 nmol/mL. Regardless of the initial diagnosis, subjects with elevated adduct levels demonstrated the clinical profile and hyperacute biochemical injury pattern associated with acetaminophen overdose: a predominance of female gender, very high aminotransferase levels, and low bilirubin levels. Conclusion: These data confirm and extend previous observations regarding the high (18%) prevalence of unrecognized or uncertain acetaminophen toxicity among subjects with indeterminate acute liver failure. N-Acetylcysteine use was limited in this group, presumably because of the lack of a specific diagnosis of acetaminophen toxicity.

Original languageEnglish (US)
Pages (from-to)567-576
Number of pages10
JournalHepatology
Volume53
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Acute Liver Failure
Acetaminophen
Liver Failure
Wounds and Injuries
Acetylcysteine
Transaminases
Serum
Bilirubin
Registries
Liver

ASJC Scopus subject areas

  • Hepatology

Cite this

Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. / Khandelwal, Niraj; James, Laura P.; Sanders, Corron; Larson, Anne M.; Lee, William M.

In: Hepatology, Vol. 53, No. 2, 02.2011, p. 567-576.

Research output: Contribution to journalArticle

Khandelwal, Niraj ; James, Laura P. ; Sanders, Corron ; Larson, Anne M. ; Lee, William M. / Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. In: Hepatology. 2011 ; Vol. 53, No. 2. pp. 567-576.
@article{917f494674634f03b9c573b8169cfc55,
title = "Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure",
abstract = "Despite extensive investigations, the cause of liver injury in 14{\%} of patients with acute liver failure remains unknown (indeterminate). In a pilot study using a novel assay, highly specific acetaminophen-cysteine adducts were detected in 7 of 36 indeterminate patients (19{\%}). To extend these observations, sera from 110 subjects enrolled in the Acute Liver Failure Study Group registry with indeterminate acute liver failure were analyzed with a similar but more efficient and sensitive adduct assay. As positive controls, another 199 patients with known or presumed acetaminophen-induced liver failure were assessed for the presence and quantity of adducts. Clinical, laboratory, and outcome data were compared for the two groups. On the basis of previous data for known therapeutic exposures and acetaminophen overdoses, an adduct concentration ≥1.0 nmol/mL of serum indicated a definite acetaminophen overdose. Among the 110 indeterminate cases, 18{\%} had assay values ≥1.0 with a median level of 9.2 nmol/mL; 94.5{\%} of the positive controls (known acetaminophen cases) had values ≥1.0 nmol/mL. Regardless of the initial diagnosis, subjects with elevated adduct levels demonstrated the clinical profile and hyperacute biochemical injury pattern associated with acetaminophen overdose: a predominance of female gender, very high aminotransferase levels, and low bilirubin levels. Conclusion: These data confirm and extend previous observations regarding the high (18{\%}) prevalence of unrecognized or uncertain acetaminophen toxicity among subjects with indeterminate acute liver failure. N-Acetylcysteine use was limited in this group, presumably because of the lack of a specific diagnosis of acetaminophen toxicity.",
author = "Niraj Khandelwal and James, {Laura P.} and Corron Sanders and Larson, {Anne M.} and Lee, {William M.}",
year = "2011",
month = "2",
doi = "10.1002/hep.24060",
language = "English (US)",
volume = "53",
pages = "567--576",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure

AU - Khandelwal, Niraj

AU - James, Laura P.

AU - Sanders, Corron

AU - Larson, Anne M.

AU - Lee, William M.

PY - 2011/2

Y1 - 2011/2

N2 - Despite extensive investigations, the cause of liver injury in 14% of patients with acute liver failure remains unknown (indeterminate). In a pilot study using a novel assay, highly specific acetaminophen-cysteine adducts were detected in 7 of 36 indeterminate patients (19%). To extend these observations, sera from 110 subjects enrolled in the Acute Liver Failure Study Group registry with indeterminate acute liver failure were analyzed with a similar but more efficient and sensitive adduct assay. As positive controls, another 199 patients with known or presumed acetaminophen-induced liver failure were assessed for the presence and quantity of adducts. Clinical, laboratory, and outcome data were compared for the two groups. On the basis of previous data for known therapeutic exposures and acetaminophen overdoses, an adduct concentration ≥1.0 nmol/mL of serum indicated a definite acetaminophen overdose. Among the 110 indeterminate cases, 18% had assay values ≥1.0 with a median level of 9.2 nmol/mL; 94.5% of the positive controls (known acetaminophen cases) had values ≥1.0 nmol/mL. Regardless of the initial diagnosis, subjects with elevated adduct levels demonstrated the clinical profile and hyperacute biochemical injury pattern associated with acetaminophen overdose: a predominance of female gender, very high aminotransferase levels, and low bilirubin levels. Conclusion: These data confirm and extend previous observations regarding the high (18%) prevalence of unrecognized or uncertain acetaminophen toxicity among subjects with indeterminate acute liver failure. N-Acetylcysteine use was limited in this group, presumably because of the lack of a specific diagnosis of acetaminophen toxicity.

AB - Despite extensive investigations, the cause of liver injury in 14% of patients with acute liver failure remains unknown (indeterminate). In a pilot study using a novel assay, highly specific acetaminophen-cysteine adducts were detected in 7 of 36 indeterminate patients (19%). To extend these observations, sera from 110 subjects enrolled in the Acute Liver Failure Study Group registry with indeterminate acute liver failure were analyzed with a similar but more efficient and sensitive adduct assay. As positive controls, another 199 patients with known or presumed acetaminophen-induced liver failure were assessed for the presence and quantity of adducts. Clinical, laboratory, and outcome data were compared for the two groups. On the basis of previous data for known therapeutic exposures and acetaminophen overdoses, an adduct concentration ≥1.0 nmol/mL of serum indicated a definite acetaminophen overdose. Among the 110 indeterminate cases, 18% had assay values ≥1.0 with a median level of 9.2 nmol/mL; 94.5% of the positive controls (known acetaminophen cases) had values ≥1.0 nmol/mL. Regardless of the initial diagnosis, subjects with elevated adduct levels demonstrated the clinical profile and hyperacute biochemical injury pattern associated with acetaminophen overdose: a predominance of female gender, very high aminotransferase levels, and low bilirubin levels. Conclusion: These data confirm and extend previous observations regarding the high (18%) prevalence of unrecognized or uncertain acetaminophen toxicity among subjects with indeterminate acute liver failure. N-Acetylcysteine use was limited in this group, presumably because of the lack of a specific diagnosis of acetaminophen toxicity.

UR - http://www.scopus.com/inward/record.url?scp=79251493760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251493760&partnerID=8YFLogxK

U2 - 10.1002/hep.24060

DO - 10.1002/hep.24060

M3 - Article

VL - 53

SP - 567

EP - 576

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 2

ER -